Breakthrough vaccine targets tick-borne bovine anaplasmosis in cattle

University of Missouri researchers are working to develop the first-ever vaccine proven to protect cattle from a devastating tick-borne cattle disease known as bovine anaplasmosis.

Masimo proxy fight heats up as ISS backs activist’s board nominees

Dive Brief: Masimo shareholders should elect both board candidates nominated by activist investor Politan Capital Management, proxy advisory firm Institutional Shareholder Services said Tuesday. Politan,

June 15, 2023

Deerfield adds another academic partner in $130M Washington University pact

Healthcare investment firm Deerfield Management has created another company to partner up with academia, and it’s promising up to $130 million over 10 years to

January 17, 2024

AbbVie taps Umoja for new in vivo CAR-T deal

AbbVie penned two deals with Umoja Biopharma for its in vivo CAR-T cell therapy programs, the companies announced Thursday. AbbVie gets an option to license

January 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.